Naman Capital’s Merck MRK Stock Holding History

Naman Capital’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-120,000	Closed	-$10.3M	–	17
2022 Q3	$10.3M	Hold	120,000	–	–	7.2%	4
2022 Q2	$10.9M	Hold	120,000	–	–	7.8%	3
2022 Q1	$9.85M	Hold	120,000	–	–	6.41%	5
2021 Q4	$9.2M	Hold	120,000	–	–	5.39%	9
2021 Q3	$9.01M	Hold	120,000	–	–	5.55%	9
2021 Q2	$9.33M	Sell	120,000 -5,760	-5%	-$428K	4.86%	10
2021 Q1	$9.25M	Hold	125,760	–	–	5.09%	9
2020 Q4	$9.82M	Hold	125,760	–	–	6.81%	7
2020 Q3	$10.2M	Hold	125,760	–	–	7.92%	5
2020 Q2	$9.28M	Hold	125,760	–	–	7.56%	6
2020 Q1	$9.23M	Hold	125,760	–	–	9.43%	3
2019 Q4	$10.9M	Hold	125,760	–	–	10.45%	4
2019 Q3	$10.1M	Hold	125,760	–	–	9.96%	5
2019 Q2	$10.1M	Sell	125,760 -571,668	-82%	-$43.8M	10.01%	4
2019 Q1	$596K	Buy	697,428 +571,668	+455%	+$42.8M	0.75%	17
2018 Q4	$9.17M	Buy	+125,760	New	+$8.88M	7.81%	3

Other funds holding MRK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

AWA

Arete Wealth Advisors Chicago, Illinois $1.33B AUM 25.12% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Naman Capital's MRK Position: Q4 2022 in Review

Naman Capital sold out of Merck (MRK) in Q4 2022, closing a stake of 120,000 shares — an estimated $10.3M sold.

Naman Capital first reported a position in MRK in Q4 2018 and held it in 16 quarters. The position peaked at $10.9M in Q2 2022. 3,234 funds tracked by Wall St. Rank hold MRK as of Q4 2022.

Naman Capital reported no remaining Merck position as of Q4 2022 after selling out during the quarter.
Naman Capital sold 120,000 Merck shares in Q4 2022, an estimated $10.3M.
Naman Capital first reported a position in Merck in Q4 2018 and held it in 16 quarters.
Naman Capital's Merck position peaked at $10.9M in Q2 2022.
3,234 funds tracked by Wall St. Rank held Merck as of Q4 2022.

Based on Naman Capital's 13F filing for Q4 2022, filed 14 Feb 2023.